BFIM
BIIB icon

Beese Fulmer Investment Management’s Biogen BIIB Stock Holding History

Beese Fulmer Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
5,959
+1,156
+24% +$221K 0.07% 142
2026
Q1 		$881K Buy
4,803
+2,531
+111% +$466K 0.06% 159
2025
Q4 		$400K Buy
+2,272
New +$371K 0.03% 233
2020
Q3 		– Sell
-20
Closed -$5K – 235
2020
Q2 		$5K Buy
+20
New +$6.01K ﹤0.01% 526

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Beese Fulmer Investment Management's BIIB Position: Q2 2026 in Review

Beese Fulmer Investment Management increased its Biogen (BIIB) stake by 24% in Q2 2026, buying an estimated $221K and bringing the position to 5,959 shares worth $1.29M. The position accounts for 0.07% of the portfolio, ranked #142.

Beese Fulmer Investment Management first reported a position in BIIB in Q2 2020 and has held it in 4 quarters since. 368 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Beese Fulmer Investment Management held 5,959 shares of Biogen worth $1.29M as of Q2 2026.
  • Beese Fulmer Investment Management bought 1,156 Biogen shares in Q2 2026, an estimated $221K.
  • Biogen made up 0.07% of Beese Fulmer Investment Management's portfolio in Q2 2026, its #142 holding.
  • Beese Fulmer Investment Management first reported a position in Biogen in Q2 2020 and has held it in 4 quarters since.
  • 368 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Beese Fulmer Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.